Cardiotrack, a startup that provides predictive diagnosis for cardiovascular diseases has inked a Memorandum of Understanding (MoU) with Grupo Seara, one of the largest entrepreneurial healthcare services companies in Mexico according to which Grupo Seara will adopt advanced patient-centric technologies from Cardiotrack to deliver high-level operational efficiency and quality diagnostics for the patients at an affordable cost.
The MoU was signed at the TEPC event, 2017 in the presence of the senior leadership teams from both companies. A similar MoU was signed with Cardiologs, a French AI company.
“It gives us great pleasure to collaborate with internationally reputed companies. It is a testimony of our commitment to make healthcare delivery more efficient, effective and affordable through innovative healthcare products. Since Cardiotrack’s inception in September 2015, approximately over 16,000 patient scans have been done using over 200 devices. The deployments have been in India as well as in countries such as Myanmar, Indonesia, Mexico and US,” said Ashim Roy, co-founder, Cardiotrack.
Founded by industry veterans Ashim Roy and Avin Agrawal, the Cardiotrack platform is designed to fulfill the basic requirements of primary care. Using Cardiotrack, doctors can detect heart health problems accurately, consult specialists, refer and track patients, maintain medical history and start the intervention process.
Cardiotrack platform includes multi-parameter, light weight healthcare IoT devices and mobile health software that helps screen illnesses such as cardiovascular diseases and hypertension, and helps doctors perform diagnosis and then safely store the patient records.
Cardiotrack’s parent company uber Diagnostics is headquartered in Singapore. The company employs highly evolved technology in medical electronics, data analytics, cloud storage and diagnostics workflow management.